Analyst firms · Leerink Partners · AMED

Leerink Partners AMED price target and rating history

Amedisys Inc (AMED) · Health Care

Leerink Partners rates Amedisys Inc (AMED) Market Perform with a $147 price target, as of its latest action on Feb 18, 2022. It has published 3 rating actions on AMED since September 2021, including 0 upgrades and 0 downgrades.

Current rating
Market Perform
Price target
$147
Median target, all firms
Too few
Actions on AMED
3

Leerink Partners price target on AMED

$181$164$14720222023202420252026
Leerink Partners price target on AMED, each point a stated target, September 2021 to February 2022.

Every Leerink Partners rating on AMED

Questions about Leerink Partners and AMED

What is Leerink Partners's price target for AMED?
Leerink Partners's latest stated price target for Amedisys Inc (AMED) is $147, from its action on Feb 18, 2022.
What is Leerink Partners's rating on AMED?
Leerink Partners rates AMED Market Perform, a neutral rating, as of Feb 18, 2022.
When did Leerink Partners last change its view on AMED?
On Feb 18, 2022, Leerink Partners raises its price target to $147 from $145, keeps Market Perform.

More AMED rating histories

All Leerink Partners ratingsAMED news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.